Author

J. C. Porter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Organism:mouse· 1

Frequent Co-Authors

A. A. Khawaja· 2 shared D. L. W. Chong· 2 shared H. L. Booth· 2 shared J. Sahota· 2 shared M. Rodriguez-Justo· 2 shared C. Gomes· 1 shared C. J. Scotton· 1 shared C. McCarthy· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. A. Khawaja

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Chemotherapeutic regulation of the ROS/MondoA-dependent TXNIP/GDF15 axis; and derivation of a new organoid metric as a predictive biomarker

J. Deng, T. Pan, Y. Hong, Z. Liu, X. Zhou, Z. An, L. Li, G. Alfano, G. Li, L. Dolcetti, R. Evans, J. M. Vicencio, P. Vlckova, Y. Chen, J. Monypenny, , T. Ng

The paper identifies chemotherapy-induced TXNIP as a negative regulator of GDF15 in CRC, showing its potential as a prognostic biomarker through organoid models.

bioRxiv · Aug 10, 2023 · PreprintCancer Biology

Platelet counts predict prognosis in IPF, but are not the main source of pulmonary TGFβ1

D. L. W. Chong, T. A. Mikolasch, J. Sahota, C. Rebeyrol, H. S. Garthwaite, H. L. Booth, M. Heightman, R. Jose, A. A. Khawaja, M. Labelle, C. J. Scotton, J. C. Porter

bioRxiv · Mar 6, 2020 · PreprintCell Biology

Identification of a novel HIF-1α-αMβ2 Integrin-NETosis axis in fibrotic interstitial lung disease

A. A. Khawaja, D. L. W. Chong, J. Sahota, C. Pericleous, V. M. Ripoll, H. L. Booth, S. Khan, M. Rodriguez-Justo, I. P. Giles, J. C. Porter

This study identifies a novel HIF-1α-αMβ2 integrin-NETosis axis in fibrotic interstitial lung disease, showing hypoxia enhances NETosis and integrin expression.

bioRxiv · Jan 3, 2020Immunology